Clinical Trial Update: Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sirolimus, everolimus, and zotarolimus-eluting stents in bifurcated coronary lesions to evaluate outcomes and the clinical significance …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis

Drugs mentioned

• Everolimus (everolimus)
• Sirolimus (Sirolimus)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Coronary Artery Disease, Coronary Stenosis | Phase 4 | Status: COMPLETED